Alaska Wealth Advisors’s Bio-Techne TECH Stock Holding History

Alaska Wealth Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-8,000	Closed	-$397K	–	58
2019 Q2	$397K	Hold	8,000	–	–	0.04%	50
2019 Q1	$397K	Hold	8,000	–	–	0.04%	50
2018 Q4	$289K	Hold	8,000	–	–	0.09%	47
2018 Q3	$408K	Hold	8,000	–	–	0.12%	35
2018 Q2	$295K	Hold	8,000	–	–	0.09%	39
2018 Q1	$302K	Hold	8,000	–	–	0.1%	37
2017 Q4	$259K	Buy	+8,000	New	+$254K	0.09%	39

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

MPI

Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Alaska Wealth Advisors's TECH Position: Q3 2019 in Review

Alaska Wealth Advisors sold out of Bio-Techne (TECH) in Q3 2019, closing a stake of 8,000 shares — an estimated $397K sold.

Alaska Wealth Advisors first reported a position in TECH in Q4 2017 and held it in 7 quarters. The position peaked at $408K in Q3 2018. 341 funds tracked by Wall St. Rank hold TECH as of Q3 2019.

Alaska Wealth Advisors reported no remaining Bio-Techne position as of Q3 2019 after selling out during the quarter.
Alaska Wealth Advisors sold 8,000 Bio-Techne shares in Q3 2019, an estimated $397K.
Alaska Wealth Advisors first reported a position in Bio-Techne in Q4 2017 and held it in 7 quarters.
Alaska Wealth Advisors's Bio-Techne position peaked at $408K in Q3 2018.
341 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2019.

Based on Alaska Wealth Advisors's 13F filing for Q3 2019, filed 18 Nov 2019.